CircRNA Synthesis Market
Report ID: SQMIG35J2714
Report ID: SQMIG35J2714
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35J2714 |
Region:
Global |
Published Date: August, 2026
Pages:
157
|Tables:
172
|Figures:
79
Global Circrna Synthesis Market size was valued at USD 420.0 Million in 2024 and is poised to grow from USD 498.12 Million in 2025 to USD 1949.9 Million by 2033, growing at a CAGR of 18.6% during the forecast period (2026-2033).
The global circular RNA (circRNA) synthesis market has emerged as a pivotal segment of the nucleic‑acid therapeutics industry, driven primarily by the expanding understanding of circRNA’s stability and regulatory functions. Historically, research on linear RNAs dominated, but breakthroughs in high‑throughput sequencing during the 2010s revealed abundant endogenous circRNAs, prompting biotech firms to invest in synthetic platforms. Companies such as Exonum and RiboTech now offer enzymatic and kits that enable production of circRNA for functional studies. This shift from discovery to manufacturing underscores why the market matters: it transforms a biological insight into a pipeline for diagnostics, vaccines, and gene‑editing tools. The expanding availability of synthesis kits has fueled investment in circRNA‑based therapeutics, because manufacturers can now generate quantities for preclinical and clinical programs without cost. This has opened opportunities in vaccine development, where circRNA’s resistance to exonucleases enables longer antigen expression compared with mRNA, exemplified by recent trials of circRNA‑encoded influenza hemagglutinin that achieved durable immune responses in murine models. Moreover, the platform’s modularity supports redesign for pathogens, attracting partnerships between biotech startups and pharmaceutical firms seeking flexible pipelines. Consequently, the market anticipates a compound annual growth rate exceeding 20 % through 2030 as regulatory pathways mature and production scale improves.
How is AI-driven automation influencing the circRNA synthesis market?
AI driven automation is reshaping the circRNA synthesis market by linking machine learning design tools with robotic synthesis lines. Algorithms predict optimal circularization motifs, while integrated liquid handling robots execute transcription, ligation and purification without manual intervention. This reduces human error, shortens batch cycles and enables rapid scaling from research to clinical grade material. Vendors are embedding real time analytics that monitor reaction yields and adjust parameters on the fly, creating a feedback loop that improves consistency. As a result, developers can move from concept to pre clinical testing in weeks rather than months, accelerating therapeutic pipelines and attracting investment.Integrated DNA Technologies announced in June 2023, an AI powered automated circRNA synthesis platform that cuts turnaround time and boosts reproducibility, helping researchers launch projects faster and supporting market expansion through higher efficiency and lower cost. The solution also includes real time quality monitoring, ensuring consistent batch performance across scales.
Market snapshot - (2026-2033)
Global Market Size
USD 420.0 Million
Largest Segment
circRNA Synthesis Kits
Fastest Growth
Custom circRNA Synthesis Services
Growth Rate
18.6% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global circrna synthesis market is segmented by product type, synthesis method, application, end user, scale, distribution channel and region. Based on product type, the market is segmented into circRNA Synthesis Kits, circRNA Reagents and Custom circRNA Synthesis Services. Based on synthesis method, the market is segmented into In Vitro Transcription, Enzymatic Circularization and Chemical Synthesis. Based on application, the market is segmented into Drug Discovery, Vaccine Development, Basic Research and Others. Based on end user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes and Others. Based on scale, the market is segmented into Research Grade and GMP Grade. Based on distribution channel, the market is segmented into Direct Sales, Distributors and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
CircRNA reagents segment dominates because it provides researchers with ready to use components that simplify assay design and reduce experimental variability. These reagents integrate high purity nucleotides, optimized ligases, and validated buffers, which accelerate workflow from transcription to circularization. Their reliability and compatibility with existing platforms foster widespread adoption, making them the preferred choice for both early stage investigations and translational projects within the circRNA synthesis market and expanding future.
However, custom circRNA synthesis services segment emerges as the most rapidly expanding area because customers increasingly seek turnkey solutions that bypass in house optimization. Service providers leverage expertise and scalable platforms to deliver bespoke circular RNAs with modifications, meeting rising demand from therapeutic and vaccine pipelines. This flexibility fuels momentum and opens opportunities.
In Vitro Transcription segment leads because it remains the foundational step for generating linear precursors with high fidelity. The method benefits from well established polymerases, robust template design, and scalable reactions that fit both academic labs and industrial pipelines. Its compatibility with diverse downstream processes and ease of optimization drive broad acceptance, ensuring that most circRNA projects initiate with this approach before adding circularization steps in the workflow efficiently.
Meanwhile, chemical synthesis segment is witnessing the strongest growth momentum because it enables precise incorporation of modified nucleotides and site specific backbone alterations that are difficult to achieve enzymatically. This capability expands the design space for therapeutic circRNAs, attracting interest from biotech innovators and accelerating the development of next generation RNA medicines.
To get detailed segments analysis, Request a Free Sample Report
North America enjoys a confluence of deep scientific expertise, extensive research infrastructure, and a culture that encourages rapid translation of discovery into application. Leading universities and research hospitals generate a steady pipeline of innovative circRNA technologies, while a mature venture ecosystem supplies the capital necessary to accelerate development. Robust regulatory pathways and clear intellectual property protections give confidence to both startups and established biotech firms. Strategic alliances between academia, government laboratories, and pharmaceutical giants foster collaborative environments that accelerate product pipelines. Additionally, a skilled workforce fluent in advanced molecular techniques and bioinformatics supports high‑throughput synthesis and validation. These combined strengths create an ecosystem where cutting‑edge circRNA research can move swiftly from bench to market, reinforcing the region’s leadership.
United States CircRNA Synthesis Market
CircRNA Synthesis Market activity in the United States is driven by world‑class academic centers that pioneer novel circular RNA designs and by a venture landscape that rapidly funds promising projects. Established biotech clusters provide integrated services from synthesis to scale‑up, while strong collaborations with major pharmaceutical companies streamline translational pathways. Regulatory clarity and a protective IP regime further incentivize investment, fostering a vibrant pipeline of therapeutic candidates. The presence of specialized contract manufacturing organizations ensures reliable production capacity, reinforcing the United States as a hub for advanced circRNA initiatives.
Canada CircRNA Synthesis Market
CircRNA Synthesis Market development in Canada benefits from a collaborative research network linking universities, government institutes, and emerging biotech firms. Federal research grants and provincial incentives encourage exploration of circular RNA applications in health and agriculture. A growing pool of skilled scientists and engineers supports sophisticated synthesis platforms, while partnerships with North American pharmaceutical players enhance translational prospects. The Canadian ecosystem emphasizes sustainable growth and open science, positioning the country as an innovative contributor to the broader circRNA landscape.
Europe’s expansion is propelled by strong governmental support for innovative therapies, coordinated research frameworks, and a dense concentration of pharmaceutical powerhouses. Multi‑national research consortia facilitate knowledge sharing across borders, accelerating discovery and validation of circular RNA constructs. Robust funding mechanisms and tax incentives encourage both established corporations and agile startups to invest in advanced synthesis capabilities. A focus on personalized medicine aligns with circRNA’s potential for targeted therapeutics, while stringent yet predictable regulatory environments build confidence among stakeholders. High‑quality talent pools and state‑of‑the‑art facilities across the continent underpin scalable production, reinforcing Europe’s position as a dynamic growth engine for circRNA technologies.
Germany CircRNA Synthesis Market
CircRNA Synthesis Market activity in Germany is anchored by a strong pharmaceutical base and a tradition of precision engineering. Leading research institutes collaborate closely with biotech firms to advance circular RNA methodologies, while a well‑established network of contract service providers offers reliable synthesis and analytical support. Government innovation programs prioritize translational research, fostering rapid movement from concept to clinical assessment. The country’s emphasis on quality and regulatory compliance ensures that German circRNA outputs meet stringent international standards, reinforcing its reputation as a dominant player.
United Kingdom CircRNA Synthesis Market
CircRNA Synthesis Market growth in the United Kingdom is accelerated by a vibrant biotech ecosystem centered around world‑renowned academic hospitals and research hubs. Substantial public and private funding streams target cutting‑edge nucleic acid therapeutics, fostering a pipeline rich in innovative circular RNA candidates. Collaborative platforms linking universities, contract manufacturers, and pharma companies streamline development cycles. The United Kingdom’s regulatory framework balances rigor with flexibility, encouraging rapid progression of promising therapies. This environment, combined with a skilled talent pool, positions the United Kingdom as the fastest‑growing market within Europe.
France CircRNA Synthesis Market
CircRNA Synthesis Market emergence in France is supported by a strong emphasis on biomedical research and a growing number of biotech incubators. National research agencies provide targeted funding that nurtures early‑stage circular RNA projects, while partnerships with multinational pharmaceutical firms enhance translational capacity. French laboratories excel in chemical synthesis and bioinformatics, contributing to sophisticated design and validation processes. A regulatory landscape that encourages innovation while maintaining safety standards further stimulates development. These elements collectively foster an emerging circRNA sector poised for accelerated advancement.
Asia Pacific is capitalizing on decisive governmental initiatives, burgeoning biotech entrepreneurship, and deep expertise in nucleic acid technologies to cement its role in circRNA synthesis. Strategic investments in research infrastructure and incentives for advanced therapeutics create fertile ground for innovation. Collaborative networks that integrate academic excellence with agile start‑up cultures accelerate discovery and scale‑up of circular RNA platforms. The region’s strong manufacturing base, coupled with a focus on precision medicine, enables efficient translation from laboratory to clinic. Cultural emphasis on rapid adoption of new health technologies further drives market momentum, positioning Asia Pacific as a dynamic and increasingly influential contributor to the global circRNA ecosystem.
Japan CircRNA Synthesis Market
CircRNA Synthesis Market progress in Japan is driven by a legacy of excellence in molecular biology and a national commitment to advanced healthcare solutions. Prominent research institutions partner with biotech firms to pioneer circular RNA applications, while government programs provide substantial backing for translational research. The country’s sophisticated manufacturing sector offers high‑quality synthesis services, and a regulatory approach that balances innovation with patient safety facilitates clinical advancement. This integrated ecosystem supports Japan’s ascent as a key player in the circRNA arena.
South Korea CircRNA Synthesis Market
CircRNA Synthesis Market activity in South Korea benefits from aggressive investment in biotech innovation and a collaborative culture between academia and industry. Governmental incentives prioritize cutting‑edge RNA therapeutics, encouraging rapid development of circular RNA platforms. A network of specialized contract manufacturers delivers reliable synthesis and analytical capabilities, while strong intellectual property frameworks protect emerging technologies. The convergence of skilled scientific talent and strategic support positions South Korea as an accelerating force in the circRNA synthesis landscape.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rapid Advancement in Synthetic Biology
Expanding Clinical Applications for circRNA
High Production Cost Challenges
Limited Regulatory Guidance Worldwide
Request Free Customization of this report to help us to meet your business objectives.
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global circRNA synthesis market is propelled primarily by rapid advances in synthetic biology that shorten turnaround times and improve construct fidelity, while a second strong engine is the expanding clinical application of circRNA in vaccines and therapeutics. The most significant restraint remains the high production cost associated with specialized enzymes and extensive purification, which limits adoption by smaller labs. North America continues to dominate due to its deep research ecosystem, venture capital support, and clear regulatory pathways. Within the market, the circRNA reagents segment holds the largest share because ready‑to‑use components simplify workflows and lower experimental variability, reinforcing overall growth.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 420.0 Million |
| Market size value in 2033 | USD 1949.9 Million |
| Growth Rate | 18.6% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the CircRNA Synthesis Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the CircRNA Synthesis Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the CircRNA Synthesis Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the CircRNA Synthesis Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
